Andere talen Edwards Lifesciences Corporation London S.E.

Aandelen

0REN

US28176E1082

Beurs gesloten - London S.E. Andere beurzen 15:34:46 05-02-2021			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
77,56 ^CHF	+5,72%		-.--%	-.--%

05/06	Edwards Lifesciences kondigt resultaten aan van de analyse van gegevens van PARTNER-trials die de resultaten van patiënten met een kleine annulus bij transkatheter aortaklepvervanging onderzoeken	CI
05/06	Transcript : Edwards Lifesciences Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 10:30 AM

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR	05/06
Edwards Lifesciences Announces Results from Analysis of Data from Partner Trials Examining Outcomes of Transcatheter Aortic Valve Replacement Patients with Small Annulus	05/06
Sector Update: Health Care Stocks Steady Premarket Monday	03/06
Edwards Lifesciences : Autodesk, Gamestop, Nvidia... les valeurs à suivre aujourd'hui à Wall Street -	03/06
Edwards Lifesciences : cède sa filiale soins intensifs à Becton Dickison	03/06
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash	03/06
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln	03/06
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion	03/06
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader	03/06
Edwards Lifesciences to Sell Critical Care to BD	03/06
Becton, Dickinson and Company entered into an agreement to acquire Critical Care Product Group of Edwards Lifesciences Corporation (NYSE : EW) for $4.2 billion.	03/06
EE.UU. - Valores a seguir en Wall Street (actualizado)	31/05
Edwards Lifesciences : Charter of the Audit Committee	28/05
Some of the biggest splits in Corporate America	23/05
Edwards Lifesciences : First Quarter 2024 Fact Sheet	15/05
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	13/05
Edwards Lifesciences Faces EU Antitrust Complaint By Meril	13/05
Edwards Lifesciences hit with Meril's EU antitrust complaint	13/05
Edwards stellt Herzklappenmodell SAPIEN 3 Ultra RESILIA mit Technologie für verbesserte Haltbarkeit in Europa vor	09/05
Edwards lance la valve SAPIEN 3 Ultra RESILIA en Europe avec une technologie pour améliorer la durabilité	09/05

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Headlines

Edwards Lifesciences Corporation: het verhaal gaat verder

23 april 2024 om 21:00 uur